Economic Calendar

Tuesday, July 8, 2008

America Movil, Famsa, OdontoPrev and Tam: Latin Equity Preview

Share this history on :

By William Freebairn

July 8 (Bloomberg) -- The following stocks may have significant gains or losses in Latin American markets. Symbols are in parentheses after company names, and stock prices are from the last session.

The MSCI index of Latin American shares rose 0.2 percent to 4,384.82 yesterday. In Brazil, preferred shares are the most commonly traded class of stock.

Brazil

OdontoPrev SA (ODPV3 BS): The Brazilian dental care company may buy Prontodente Odontologia Integral Ltda. for 10 million reais ($6.2 million), OdontoPrev said in a filing posted on Brazil's securities regulator Web site yesterday. OdontoPrev paid 1 million reais for an option to buy 100 percent of Prontodente, according to the filing. OdontoPrev fell 0.6 percent to 35.49 reais.

Tam SA (TAMM4 BS): Brazil's largest airline said its June domestic market share was 49 percent. The international market share was 75 percent, Tam said in a statement sent via PR Newswire yesterday. Tam fell 1.4 percent to 24.25 reais.

Mexico

America Movil SAB (AMXL MM): Latin America's largest mobile-phone company will sell Apple Inc.'s newest iPhone in Mexico for as little as 773 pesos ($74.83) with a two-year contract. The price applies to the 8GB version of the device with a plan of 799 pesos monthly that includes 400 minutes of calling and 200 megabytes of data downloads, America Movil said on its Web site yesterday. America Movil rose 0.2 percent to 26.48 pesos.

Grupo Famsa SAB (GFAMSAA MM): Investors in the Mexican retailer with stores in the U.S. should ``be cautious in the very short term,'' Credit Suisse Group analysts including Tufic Salem wrote in a research note e-mailed yesterday. High food prices, low consumer confidence and tighter credit may affect sales in the second quarter, the analysts wrote. Famsa fell 2.2 percent to 35.78 pesos.

To contact the reporter on this story: William Freebairn in Mexico City at wfreebairn@bloomberg.net


No comments: